Peer Resources

The ACFP is a proud supporter and partner of the PEER team. Through a joint collaboration between a small group of physicians from the University of Alberta in 2009 to now, a full interdisciplinary group of pharmacists, nurses, and family physicians, the ACFP and PEER have developed an award-winning Evidence & CPD program that aims to inspire and equip clinicians to use the best evidence for shared-informed decision making with their patients.

PEER Resources

Since 2009, the ACFP has cultivated, supported, and endorsed a joint collaboration with the University of Alberta and PEER. It has been one of the most fruitful and effective collaborations producing several practice-changing resources.

• Tools for Practice – The award-winning CPD library houses more than 200 evidence summaries providing answers for broad clinical questions.
• The Pricing Document – first published by the ACFP in 2013, the Pricing Document provides of price comparison of commonly prescribed drugs.
• The Highs and Lows of Medical Cannabis – take a look at the available evidence on cannabinoids and a simplified guideline for prescribing medical cannabinoids in primary care.
• C-TOP Tool (Comparing Treatment Options for Pain) – Pain Calculator – this calculator is a tool that shows the potential benefits and possible harms associated with different treatments for pain. Additionally, it highlights key things to consider when choosing treatment, including the most common side effects or cost.
• Prevention and Management of Cardiovascular Disease Risk in Primary Care – developed and driven by family physicians, this simplified guideline offers primary and secondary prevention for cardiovascular disease (CVD) focused on CVD risk estimation and lipid management
• Simplified Guideline: Managing Opioid Use Disorder in Primary Care – developed and driven by family physicians, using the best available evidence, this guideline provides a simplified, shared decision-making approach to common questions experienced by primary care clinicians and their patients with opioid use disorder.